Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

ImmunoassayRapid Tests bioNexiaCancer - FOBplus

The bioNexia® FOBplus rapid test is a non-invasive method for colorectal cancer screening.

Very sensitive Fecal Occult Blood test

Results available at just 5 minutes

User-friendly method for increased patient comfort and easy interpretation

Colorectal cancer is one of the most common causes of death from cancer. However, if it is detected at a very early stage, there is an over 90% chance of survival. Adenomatous polyps, that have the potential to transform into cancer, tend to bleed frequently. It is known that their early removal reduces the risk of colorectal cancer1.

The bioNexia® FOBplus rapid test allows the detection in stools of human hemoglobin potentially linked to adenomatous polyps. Without automatically pointing to cancer, a positive test result indicates a disorder which should be investigated further.